These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 34331009)

  • 1. Autoantibodies against NMDA receptor 1 modify rather than cause encephalitis.
    Wilke JBH; Hindermann M; Berghoff SA; Zihsler S; Arinrad S; Ronnenberg A; Barnkothe N; Steixner-Kumar AA; Röglin S; Stöcker W; Hollmann M; Nave KA; Lühder F; Ehrenreich H
    Mol Psychiatry; 2021 Dec; 26(12):7746-7759. PubMed ID: 34331009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoantibodies against N-methyl-d-aspartate receptor 1 in health and disease.
    Ehrenreich H
    Curr Opin Neurol; 2018 Jun; 31(3):306-312. PubMed ID: 29474316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NMDAR1 autoantibodies amplify behavioral phenotypes of genetic white matter inflammation: a mild encephalitis model with neuropsychiatric relevance.
    Arinrad S; Wilke JBH; Seelbach A; Doeren J; Hindermann M; Butt UJ; Steixner-Kumar AA; Spieth L; Ronnenberg A; Pan H; Berghoff SA; Hollmann M; Lühder F; Nave KA; Bechter K; Ehrenreich H
    Mol Psychiatry; 2022 Dec; 27(12):4974-4983. PubMed ID: 34866134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uncoupling the widespread occurrence of anti-NMDAR1 autoantibodies from neuropsychiatric disease in a novel autoimmune model.
    Pan H; Oliveira B; Saher G; Dere E; Tapken D; Mitjans M; Seidel J; Wesolowski J; Wakhloo D; Klein-Schmidt C; Ronnenberg A; Schwabe K; Trippe R; Mätz-Rensing K; Berghoff S; Al-Krinawe Y; Martens H; Begemann M; Stöcker W; Kaup FJ; Mischke R; Boretius S; Nave KA; Krauss JK; Hollmann M; Lühder F; Ehrenreich H
    Mol Psychiatry; 2019 Oct; 24(10):1489-1501. PubMed ID: 29426955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple inducers and novel roles of autoantibodies against the obligatory NMDAR subunit NR1: a translational study from chronic life stress to brain injury.
    Pan H; Steixner-Kumar AA; Seelbach A; Deutsch N; Ronnenberg A; Tapken D; von Ahsen N; Mitjans M; Worthmann H; Trippe R; Klein-Schmidt C; Schopf N; Rentzsch K; Begemann M; Wienands J; Stöcker W; Weissenborn K; Hollmann M; Nave KA; Lühder F; Ehrenreich H
    Mol Psychiatry; 2021 Jun; 26(6):2471-2482. PubMed ID: 32089545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoantibodies against the
    Ehrenreich H
    Front Immunol; 2017; 8():181. PubMed ID: 28298911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. All naturally occurring autoantibodies against the NMDA receptor subunit NR1 have pathogenic potential irrespective of epitope and immunoglobulin class.
    Castillo-Gómez E; Oliveira B; Tapken D; Bertrand S; Klein-Schmidt C; Pan H; Zafeiriou P; Steiner J; Jurek B; Trippe R; Prüss H; Zimmermann WH; Bertrand D; Ehrenreich H; Hollmann M
    Mol Psychiatry; 2017 Dec; 22(12):1776-1784. PubMed ID: 27502473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoimmune encephalitis mediated by B-cell response against N-methyl-d-aspartate receptor.
    Wagnon I; Hélie P; Bardou I; Regnauld C; Lesec L; Leprince J; Naveau M; Delaunay B; Toutirais O; Lemauff B; Etard O; Vivien D; Agin V; Macrez R; Maubert E; Docagne F
    Brain; 2020 Oct; 143(10):2957-2972. PubMed ID: 32893288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic presence of blood circulating anti-NMDAR1 autoantibodies impairs cognitive function in mice.
    Yue W; Caldwell S; Risbrough V; Powell S; Zhou X
    PLoS One; 2021; 16(9):e0256972. PubMed ID: 34473764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient-Derived Anti-NMDAR Antibody Disinhibits Cortical Neuronal Networks through Dysfunction of Inhibitory Neuron Output.
    Andrzejak E; Rabinovitch E; Kreye J; Prüss H; Rosenmund C; Ziv NE; Garner CC; Ackermann F
    J Neurosci; 2022 Apr; 42(15):3253-3270. PubMed ID: 35241491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The brain as immunoprecipitator of serum autoantibodies against N-Methyl-D-aspartate receptor subunit NR1.
    Castillo-Gomez E; Kästner A; Steiner J; Schneider A; Hettling B; Poggi G; Ostehr K; Uhr M; Asif AR; Matzke M; Schmidt U; Pfander V; Hammer C; Schulz TF; Binder L; Stöcker W; Weber F; Ehrenreich H
    Ann Neurol; 2016 Jan; 79(1):144-51. PubMed ID: 26505629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimizing animal models of autoimmune encephalitis using active immunization.
    Linnoila J; Jalali Motlagh N; Jachimiec G; Lin CJ; Küllenberg E; Wojtkiewicz G; Tanzi R; Chen JW
    Front Immunol; 2023; 14():1177672. PubMed ID: 37520559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inducing sterile pyramidal neuronal death in mice to model distinct aspects of gray matter encephalitis.
    Wilke JBH; Hindermann M; Moussavi A; Butt UJ; Dadarwal R; Berghoff SA; Sarcheshmeh AK; Ronnenberg A; Zihsler S; Arinrad S; Hardeland R; Seidel J; Lühder F; Nave KA; Boretius S; Ehrenreich H
    Acta Neuropathol Commun; 2021 Jul; 9(1):121. PubMed ID: 34215338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glutamate receptor antibodies in neurological diseases: anti-AMPA-GluR3 antibodies, anti-NMDA-NR1 antibodies, anti-NMDA-NR2A/B antibodies, anti-mGluR1 antibodies or anti-mGluR5 antibodies are present in subpopulations of patients with either: epilepsy, encephalitis, cerebellar ataxia, systemic lupus erythematosus (SLE) and neuropsychiatric SLE, Sjogren's syndrome, schizophrenia, mania or stroke. These autoimmune anti-glutamate receptor antibodies can bind neurons in few brain regions, activate glutamate receptors, decrease glutamate receptor's expression, impair glutamate-induced signaling and function, activate blood brain barrier endothelial cells, kill neurons, damage the brain, induce behavioral/psychiatric/cognitive abnormalities and ataxia in animal models, and can be removed or silenced in some patients by immunotherapy.
    Levite M
    J Neural Transm (Vienna); 2014 Aug; 121(8):1029-75. PubMed ID: 25081016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoantibodies against the NMDAR subunit NR1 are associated with neuropsychiatric outcome after ischemic stroke.
    Deutsch NR; Worthmann H; Steixner-Kumar AA; Schuppner R; Grosse GM; Pan H; Gabriel MM; Hasse I; van Gemmeren T; Lichtinghagen R; Ehrenreich H; Weissenborn K
    Brain Behav Immun; 2021 Aug; 96():73-79. PubMed ID: 34010714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preexisting Serum Autoantibodies Against the NMDAR Subunit NR1 Modulate Evolution of Lesion Size in Acute Ischemic Stroke.
    Zerche M; Weissenborn K; Ott C; Dere E; Asif AR; Worthmann H; Hassouna I; Rentzsch K; Tryc AB; Dahm L; Steiner J; Binder L; Wiltfang J; Sirén AL; Stöcker W; Ehrenreich H
    Stroke; 2015 May; 46(5):1180-6. PubMed ID: 25765725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoantibodies against NMDAR subunit NR1 disappear from blood upon anesthesia.
    Teller J; Jung C; Wilke JBH; Schimmelpfennig SD; Hindermann M; Hinken L; Gabriel MM; Fegbeutel C; Schäfer A; Laser H; Lichtinghagen R; Worthmann H; Weissenborn K; Ehrenreich H
    Brain Behav Immun Health; 2022 Oct; 24():100494. PubMed ID: 35965838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuropsychiatric disease relevance of circulating anti-NMDA receptor autoantibodies depends on blood-brain barrier integrity.
    Hammer C; Stepniak B; Schneider A; Papiol S; Tantra M; Begemann M; Sirén AL; Pardo LA; Sperling S; Mohd Jofrry S; Gurvich A; Jensen N; Ostmeier K; Lühder F; Probst C; Martens H; Gillis M; Saher G; Assogna F; Spalletta G; Stöcker W; Schulz TF; Nave KA; Ehrenreich H
    Mol Psychiatry; 2014 Oct; 19(10):1143-9. PubMed ID: 23999527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Anti-nMDA receptor encephalitis--clinical manifestations and pathophysiology].
    Iizuka T; Sakai F
    Brain Nerve; 2008 Sep; 60(9):1047-60. PubMed ID: 18807939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stereotactic injection of cerebrospinal fluid from anti-NMDA receptor encephalitis into rat dentate gyrus impairs NMDA receptor function.
    Würdemann T; Kersten M; Tokay T; Guli X; Kober M; Rohde M; Porath K; Sellmann T; Bien CG; Köhling R; Kirschstein T
    Brain Res; 2016 Feb; 1633():10-18. PubMed ID: 26721688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.